All In MedTech

FDA Clearance Tracker · P200035-S006

OrganOx metra® System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 8, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 8, 2023

Approved

Time to decision

230 days

Received Dec 21, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P200035-S006
Device name
OrganOx metra® System
Applicant location
Oxford
Received
Dec 21, 2022
Decided
Aug 8, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P200035

Device type

Device class
Class III

Every decision under product code QQK

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Integrated Technologies Ltd, Viking House, Ellingham Way, Ashford, Kent, TN23 6NF, UK.

Source documents

Other decisions for Organox Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.